RecruitingNCT05988632
Intranasal insulin or placebo during alcohol cue and drinking tests
About this title
Read the official source — NCT05988632Medication studyAges 21+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 21 years.
What will I do during this study?
Participants attend two bar-laboratory sessions in a crossover design: one with intranasal insulin and one with matching saline placebo (an inactive comparison treatment), in an order determined by group. The sessions are separated by a one-week washout. Each includes an alcohol-cue task and an alcohol challenge with assessments.
- Listed locations
- ProvidenceSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 25, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Brown University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 21 Years
- Official registry ID
- NCT05988632
- Official title
Show the full official title
Intranasal Insulin for Treatment of Alcohol Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Providence
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Brown University, a university.
Does this study involve medication?
Yes. The study involves medication, including Regular Human Insulin then Placebo and Placebo then Regular Human Insulin.
Who can participate?
Listed age limits: from 21 years.
Is this study still recruiting?
The registry lists this study as recruiting.
